Silvia Scoccianti

Azienda Ospedaliero-Universitaria Careggi

Papers

1

Total Citations

23

H-Index

1

About

Silvia Scoccianti is a leading figure in radiation oncology, with a specialized focus on stereotactic body radiotherapy (SBRT) for complex and challenging tumor sites. Her research has significantly advanced the application of high-precision radiation techniques, particularly for cardiac malignancies, where traditional radiotherapy has been limited by radiobiological and technical constraints. Her seminal 2015 work, "Stereotactic Body Radiotherapy with Cyberknife for Cardiac Malignancies," has garnered 23 citations, underscoring its impact in opening new therapeutic avenues for patients with primary and secondary cardiac tumors. By demonstrating the feasibility and safety of delivering focused, high-dose radiation to the heart, Scoccianti has helped redefine the role of SBRT in managing these rare and life-threatening conditions. Her contributions extend beyond cardiac oncology, influencing broader SBRT protocols and patient selection criteria. Through her meticulous clinical research, Scoccianti has established herself as a pioneer in pushing the boundaries of radiation therapy, offering hope and improved outcomes for patients with historically inoperable or radioresistant tumors.

Research Focus

Key Achievements

1
H-Index
1
Papers
23
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Stereotactic Body Radiotherapy with Cyberknife for Cardiac Malignancies
23 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago